Kolb, Leonie
Arzt, Michael
Stadler, Stefan
Heider, Katharina
Maier, Lars S.
Malfertheiner, Maximilian
Article History
Received: 26 March 2020
Revised: 10 July 2020
Accepted: 21 August 2020
First Online: 3 September 2020
Compliance with ethical standards
:
: M. Arzt reports grants and personal fees from Philips Respironics and ResMed; grants from the ResMed Foundation; and personal fees from Novartis, BresoTec, Boehringer-Ingelheim, Inspire, JAZZ Pharmaceuticals, and NRI outside the submitted work. All other authors report no conflict of interest.
: This retrospective analysis was approved by the Ethics Committee of the University of Regensburg (approval no. 15-101-0255) and was conducted in accordance with the principles of Good Clinical Practice and the Declaration of Helsinki.
: The requirement for informed consent was waived because of the retrospective study design.